Most founders walk into their first term sheet conversation focused on the valuation. The valuation matters. It is also rarely the thing that will cost them the most over the life of the company.
The clauses that compound — anti-dilution, liquidation preference, board composition, drag-along rights, protective provisions, the size and timing of the option pool — quietly determine who controls the company, who gets paid first when the exit happens, and how badly the cap table breaks if the next round prices flat or down. A founder who saved 20% on valuation by accepting a full ratchet anti-dilution clause may find, two rounds later, that they own less of their own company than the founder who took the lower price.
This article is the working glossary. Every clause that matters, in plain language, with what is standard at each stage, what to push back on, and what to accept. It is not legal advice. It is the briefing every founder should have read before their lawyer's first call.
"Founders fight for valuation. Investors fight for terms. The investor wins this trade more often than founders realise — because the terms compound and the valuation does not."
What a term sheet actually is
A term sheet is a non-binding summary of the deal the lead investor is offering. The headline economic terms (price, amount raised, ownership split) are usually 60% of the document. The other 40% is governance and rights. Almost all of it survives, in some form, into the binding closing documents that follow over the next four to eight weeks.
A handful of provisions are binding even at the term-sheet stage. Read these carefully even when the cover page says "non-binding":
- Confidentiality. Both sides agree not to disclose the terms.
- Exclusivity (no-shop). The founder cannot solicit other term sheets while this one is being negotiated.
- Expense reimbursement. The company usually agrees to pay the lead investor's legal fees up to a cap.
- Sometimes a small breakup fee if the founder walks for a non-permitted reason.
The lead drafts. You negotiate. You sign. The closing documents (Stock Purchase Agreement, Voting Agreement, Investors' Rights Agreement, Right of First Refusal Agreement) follow over four to eight weeks and convert the term sheet into legally enforceable contracts. Most negotiation leverage is at the term-sheet stage. Once it is signed, the leverage shifts to the investor.
The economics: who gets what
Pre-money vs post-money valuation
Pre-money valuation is the value of the company before the new investment. Post-money is pre-money plus the new investment. The investor's ownership is calculated as new investment divided by post-money.
Quick math: $4M pre-money plus a $1M raise equals $5M post-money. The investor owns 20%.
Almost every funding conversation should start with confirming whether a quoted valuation is pre or post. The difference is meaningful. A "$5M valuation" can mean either, and the difference is roughly 4-5 percentage points of investor ownership.
Option pool
The option pool funds future hires. Investors will require one. The question is how big and where it comes from.
The trick most first-time founders miss: pre-money option pool versus post-money option pool. A pre-money pool comes out of founder equity. A post-money pool dilutes everyone, including the new investor. In a $4M pre-money / $1M raise / 10% pool deal, founders end up with roughly 65% if the pool is pre-money and roughly 72% if the pool is post-money.
Always ask: "is the option pool pre-money or post-money?" The default in most term sheets is pre-money. The pushback is post-money or a smaller pool.
Standard sizes: 10-15% at seed, 7-12% at Series A, 5-10% at Series B and beyond.
SAFEs and convertible notes
A SAFE (Simple Agreement for Future Equity) is a promise that the next round's price will trigger a conversion of the SAFE into preferred stock at a discount, a cap, or both.
- Cap. The maximum valuation at which the SAFE converts. A lower cap means more dilution to founders when it converts.
- Discount. The SAFE converts at a percentage below the next round's price, typically 15-20%.
Stacked SAFEs are the most common cap-table mistake we see. A founder signs eight SAFEs at caps of $5M, $7M, $10M, $12M, and $15M over 18 months, never models what happens when they all convert at the priced round, and arrives at the Series A negotiation discovering they have already given away 35% of the company before the round prices.
Always model the conversion before you sign more SAFEs. Carta, Pulley, and Captable.io all have stacking calculators. Ten minutes of modelling saves percentage points of permanent dilution.
Liquidation preference
This determines who gets paid first when the company exits. It is the most consequential clause at down-round exits and the most overlooked clause at up-round exits.
- 1x non-participating preferred. The standard. The investor either takes their money back, OR converts to common and takes their pro-rata share of the proceeds. Whichever is more.
- 1x participating preferred. The investor takes their money back AND their pro-rata share of what is left after preference is paid. Founders are paid out of what remains. At a small exit, this materially eats into founder proceeds.
- Multiple preference (>1x). Aggressive. Used at later stages, troubled rounds, or in markets where investors have leverage. Avoid at early stage.
- Cap on participation. "1x participating up to a 3x cap" limits the investor's downside protection. Better than uncapped participating but still worse than 1x non-participating.
Standard at seed and Series A: 1x non-participating. Anything else is a flag. Push back hard on participating preferred at any early stage.
Anti-dilution
Anti-dilution triggers when the company raises a future round at a price below the current round's price (a "down round"). The investor's preferred share count adjusts to compensate them for the lower price.
- Broad-based weighted average. The standard. Adjusts based on the size of the down round and the number of new shares issued. Usually meaningful but not catastrophic.
- Narrow-based weighted average. Like broad-based but the formula crushes founders harder. Less common today.
- Full ratchet. Catastrophic. The investor's price gets reset to the new lower price as if they had paid that price the whole time. Founders get massively diluted, sometimes losing more than the investor lost.
Standard at seed and Series A: broad-based weighted average. Full ratchet anti-dilution at any early stage is a huge red flag. This is the single most common clause that comes back to bite founders in Series B. A flat or down Series B with full ratchet anti-dilution can effectively re-cap the company in the seed investor's favour, leaving founders with materially less ownership than they had before the round.
Pro-rata rights
The right (not the obligation) for the investor to maintain their ownership percentage in future rounds.
Standard at seed: pro-rata for all preferred holders. Mostly unobjectionable.
The bite: if you have eight SAFEs that all convert with pro-rata rights, your Series A is partially blocked from new investors before the round opens. New leads want meaningful ownership; if 35% of the round is already spoken for by pro-rata, the new lead may pass.
Negotiate: "major investor pro-rata only." Limit pro-rata to investors who took above a threshold cheque size ($250K or $500K).
Vesting
Founder vesting is standard now. Investors will require it. The question is the schedule.
Standard: 4 years with a 1-year cliff. 25% vests after year one, then monthly for three years.
Acceleration is the clause to pay attention to.
- Single-trigger acceleration. Full vesting on any change of control. Aggressive ask, sometimes granted to founders, often pushed back by acquirers because it leaves the team un-incentivised post-acquisition.
- Double-trigger acceleration. Full vesting on change of control AND termination without cause within 12 months. Standard. Push for this if not offered. It protects founders from being fired post-acquisition before their equity vests.
Founders who already have time at the company often negotiate "credit" for time already served — typically 1 year of pre-vested equity at signing.
Control: who decides what
Board composition
The board is who decides the things that matter most: hiring and firing the CEO, approving budgets, approving acquisitions, approving new financings.
- Pre-seed and small seed. Often no formal board, or 1 founder + 1 investor. Sometimes 1+1+1 (founder, investor, independent).
- Seed. 2 founders + 1 investor, or 2+1+1 (the +1 being a mutually agreed independent).
- Series A. 2+1+2 is the textbook structure. More common in practice: 2+2+1.
The bite to watch for: the independent director. A 2+2+1 board with an independent picked unilaterally by the investor is functionally a 2+3. The independent should be jointly selected, ideally from a list both sides agree on, and ideally with both sides having veto rights over the choice.
Protective provisions
The list of corporate actions that require investor approval. The standard list at seed and Series A includes:
- Changing the certificate of incorporation
- Issuing senior preferred stock
- Paying dividends
- Redeeming or repurchasing shares
- Voluntary liquidation or dissolution
- Sale of the company or material assets
- Increasing the option pool above an agreed threshold
- Taking on debt above an agreed threshold
This list is mostly fine. Investors should have a say in structural changes that affect their ownership and exit.
The bite is when the list expands to include operating decisions. Watch for: "approving any annual budget", "approving any single expenditure above $X", "hiring or firing any C-level executive", "entering any agreement above $X annual value", "approving the strategic plan." Any of these effectively gives the investor veto power over running the company. Push back hard. Keep the list to material structural changes. Do not let it touch operations.
Drag-along rights
Drag-along lets a defined majority force a minority to sell their shares in an acquisition.
Standard: the trigger requires majority approval from the preferred AND majority approval from the common (or sometimes a majority of the board). This protects founders from being forced into a sale they disagree with.
The bite: if the trigger is preferred-only, the investor can force a sale that founders oppose. Push for: trigger requires majority of common as well, or a board-level approval requirement.
Information rights
The investor's right to financial information. Usually monthly or quarterly financials, the annual budget, audited financials at later stages, and reasonable inspection rights.
Mostly unobjectionable. Just confirm the threshold for "qualified investor" rights (more detailed information, board observer rights) is set appropriately so smaller investors do not get full inspection.
Right of First Refusal (ROFR) and Co-Sale
ROFR gives the company the right to buy a founder's shares before the founder sells to a third party. Co-sale lets the investors sell pro-rata alongside any founder sale.
Both are standard. Usually unobjectionable unless the timing windows are unreasonable. Watch for windows shorter than 30 days, which can make secondary sales practically impossible.
Closing terms (the binding ones)
No-shop / exclusivity
The founder cannot solicit other term sheets while this one is being negotiated.
Standard duration: 30 to 45 days. 60 days is aggressive.
The bite: if the deal falls through after a 60-day no-shop, the founder has burned two months of fundraising momentum. By the time they re-engage other funds, the original signal of investor interest has cooled.
Negotiate: shortest possible window. 30 days is a reasonable target. Some founders successfully negotiate "30 days plus 2-week extension if both parties consent."
Expense reimbursement
The company agrees to pay the lead investor's legal fees.
Standard amounts: $25,000 to $50,000 at seed, $50,000 to $75,000 at Series A. Watch for uncapped reimbursement, or fees that are payable even if the deal does not close.
Push for: a hard cap, payable only at closing, with the founder's lawyer reviewing the bill before payment.
Conditions to closing
The list of things that must be done before the deal closes. Usually: cap table cleanup, founder vesting agreements, IP assignment confirmations, satisfactory completion of diligence, and required board approvals.
Read this carefully. Anything ambiguous gives the investor a justified walkaway. "Satisfactory completion of diligence" is normal but should be reasonable in scope. "No material adverse change" is normal but should reference an objective standard.
Reps and warranties
Statements you make about the company that the investor relies on: cap table is accurate, financials are accurate, no undisclosed liabilities, IP is owned, no pending litigation. Standard. Read the schedule of exceptions carefully — anything you forget to disclose can become a claim against you personally if it surfaces later.
What's standard at each stage
Pre-seed (SAFE or small priced round, $250K to $1M)
SAFE is the most common instrument. Cap-only or cap-plus-discount are both normal. If priced: 1x non-participating, broad-based anti-dilution, board of one founder plus one investor. Pro-rata for all preferred. Standard ROFR and co-sale.
Seed (priced round, $1M to $5M)
- Pre-money valuation. $4M to $15M (varies wildly by sector and traction).
- Option pool. 10-15%, prefer post-money sizing.
- Liquidation preference. 1x non-participating.
- Anti-dilution. Broad-based weighted average.
- Board. 2 founders + 1 investor, or 2+1+1.
- Pro-rata. Major investors only.
- No-shop. 30 days.
- Legal expense cap. $35,000 to $50,000.
Series A ($5M to $15M+)
- Pre-money valuation. $15M to $50M+.
- Option pool. 7-12%, prefer post-money sizing.
- Liquidation preference. 1x non-participating.
- Anti-dilution. Broad-based weighted average.
- Board. 2+1+1 or 2+2+1.
- Protective provisions. Expanded list, but still structural only.
- No-shop. 45 days.
- Legal expense cap. $50,000 to $75,000.
The clauses that come back to bite you
The seven term-sheet decisions that most often cause founders pain in Series B and beyond:
- Full ratchet anti-dilution at seed or Series A. A flat or down Series B can re-cap the cap table dramatically.
- Pre-money option pool at every round, sized too large. Founders end up massively diluted because the pool comes out of their share repeatedly.
- Aggressive protective provisions that touch operations. Founders find they need investor approval to hire a VP Engineering or sign a partnership deal.
- Stacked SAFEs with broad pro-rata rights. New leads at the priced round find that 30-40% of the round is already spoken for and pass.
- Drag-along triggered by preferred majority alone. Founders can be forced into a sale they oppose.
- Single-trigger acceleration applied to everyone. Acquirers push back because the team is fully vested and has no retention; the deal collapses or the price drops.
- Liquidation preference greater than 1x or participating without a cap. Founders take home meaningfully less than they expect at exit, especially in modest outcomes.
What to push back on, what to accept
Push back hard:
- Full ratchet anti-dilution
- Liquidation preference greater than 1x
- Participating preferred without a participation cap
- Protective provisions that touch operations
- Pre-money option pool that's larger than necessary
- Drag-along triggered by preferred majority alone
Negotiate:
- Option pool size and pre vs post-money sizing
- Board composition, especially the independent director
- Pro-rata rights threshold (major investors only)
- No-shop duration (30 days target)
- Legal expense reimbursement cap
Accept:
- 1x non-participating preferred
- Broad-based weighted average anti-dilution
- Standard pro-rata for preferred holders
- 4-year vesting with 1-year cliff and double-trigger acceleration
- Standard ROFR and co-sale rights
- Standard reps and warranties
- Standard information rights
This is not a universal frame. Markets, sectors, and individual deals vary. But if a term sheet you receive has multiple items in the "push back hard" column, that is meaningful information about how the lead investor sees the deal balance — and about what kind of board partner they will be.
The lawyer question
Use a US-aware lawyer if you are raising from US institutional investors. The cost is real: typically $20,000 to $40,000 in legal fees for a seed round, $50,000 to $100,000 for a Series A. The cost of not having one is much higher and shows up two years later.
Three rules:
- Do not use the investor's lawyer. They represent the investor.
- Do not use a lawyer who has never closed a venture round. A general corporate lawyer drafting a SAFE introduces clauses that block follow-on rounds. The mistakes compound.
- Do interview two or three firms before choosing. Reasonable rates, active venture practice, and partner-level attention all matter. Cooley, Wilson Sonsini, Gunderson, Goodwin, Latham, Orrick, Fenwick, and Lowenstein are the usual names; smaller specialty firms can be excellent and cheaper. Founders should ask each firm: "what's your typical seed/Series A fee, and how many similar deals have you closed in the last 12 months?"
The right lawyer also serves as a sanity check on the term sheet itself. A founder reading this glossary plus a competent venture lawyer reading the document will catch 95% of the structural issues that compound. The remaining 5% is usually deal-specific and requires negotiation rather than knowledge.
How PitchVault helps before the term sheet ever lands
The deck audit does not replace a lawyer. But the four-score audit (VaultScore™, VaultRisk™, VaultMoat™, VaultOps™) catches the company-side issues that determine what term sheet you get offered in the first place: a soft ask, a market slide that gets discounted, traction presented as logos instead of as commercial signal, a financial model that signals carelessness on the unit economics.
Investors offer materially better terms — higher valuations, cleaner participation, tighter no-shops, smaller option pools — to companies that look investor-ready before the negotiation starts. The audit puts you in that position before the conversation begins, not after.
A clean cap table, a credible deck, a well-structured data room, and a deliberately positioned market story consistently produce better term sheets than any single negotiation tactic ever has.
Score your deck against institutional-investor criteria — get the honest read in under two minutes.
